- Home
- CNET vs CERO Comparison
CNET vs CERO Comparison
Compare CNET & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- CERO
- Stock Information
- Founded
- CNET 2003
- CERO 2017
- Country
- CNET Hong Kong
- CERO United States
- Employees
- CNET N/A
- CERO N/A
- Industry
- CNET Advertising
- CERO
- Sector
- CNET Consumer Discretionary
- CERO
- Exchange
- CNET Nasdaq
- CERO Nasdaq
- Market Cap
- CNET 3.3M
- CERO 3.5M
- IPO Year
- CNET N/A
- CERO N/A
- Fundamental
- Price
- CNET $1.41
- CERO $9.93
- Analyst Decision
- CNET
- CERO Strong Buy
- Analyst Count
- CNET 0
- CERO 2
- Target Price
- CNET N/A
- CERO $45.00
- AVG Volume (30 Days)
- CNET 705.7K
- CERO 3.3M
- Earning Date
- CNET 08-15-2025
- CERO 08-13-2025
- Dividend Yield
- CNET N/A
- CERO N/A
- EPS Growth
- CNET N/A
- CERO N/A
- EPS
- CNET N/A
- CERO N/A
- Revenue
- CNET $13,560,000.00
- CERO N/A
- Revenue This Year
- CNET N/A
- CERO N/A
- Revenue Next Year
- CNET N/A
- CERO N/A
- P/E Ratio
- CNET N/A
- CERO N/A
- Revenue Growth
- CNET N/A
- CERO N/A
- 52 Week Low
- CNET $1.11
- CERO $6.71
- 52 Week High
- CNET $4.53
- CERO $895.40
- Technical
- Relative Strength Index (RSI)
- CNET 51.94
- CERO 50.09
- Support Level
- CNET $1.14
- CERO $8.12
- Resistance Level
- CNET $1.43
- CERO $13.14
- Average True Range (ATR)
- CNET 0.16
- CERO 2.83
- MACD
- CNET 0.01
- CERO 0.39
- Stochastic Oscillator
- CNET 41.54
- CERO 19.58
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.